We are live on
!
Find out more
VPIM
Vanguard Personalized Indexing Management Portfolio holdings
AUM
$10.2B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+15.09%
1 Year Est. Return
+34.45%
3 Year Est. Return
+115.18%
5 Year Est. Return
+162.91%
10 Year Est. Return
–
AUM
$8.86B
AUM Growth
+$2.08B
(+31%)
Cap. Flow
+$1.22B
Cap. Flow
% of AUM
13.81%
Top 10 Holdings %
Top 10 Hldgs %
31.49%
Holding
2,054
New
215
Increased
1,370
Reduced
347
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$91M |
| 2 |
NVIDIA
NVDA
|
+$68M |
| 3 |
Apple
AAPL
|
+$44M |
| 4 |
Amazon
AMZN
|
+$39.4M |
| 5 |
Broadcom
AVGO
|
+$32.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$6.47M |
| 2 |
Vanguard Total World Stock ETF
VT
|
+$2.83M |
| 3 |
Chevron
CVX
|
+$1.54M |
| 4 |
X
US Steel
X
|
+$1.1M |
| 5 |
iShares US Technology ETF
IYW
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.75% |
| 2 | Financials | 14.43% |
| 3 | Consumer Discretionary | 10.16% |
| 4 | Healthcare | 9.26% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Recursion Pharmaceuticals
RXRX
$1.61B
| $61.5K | ﹤0.01% |
12,153
-2,570
| -17% | -$12.6K |
|
1802
Lexeo Therapeutics
LXEO
$342M
| $60.3K | ﹤0.01% |
+15,000
| New | +$49.3K |
|
|
EWCZ
1803
DELISTED
European Wax Center
EWCZ
| $60.2K | ﹤0.01% |
+10,685
| New | +$48.5K |
|
1804
The Honest Company
HNST
$409M
| $60.1K | ﹤0.01% |
11,817
+651
| +6% | +$3.12K |
|
1805
Frontier Group Holdings
ULCC
$1.61B
| $59.1K | ﹤0.01% |
16,278
-20,433
| -56% | -$74.9K |
|
|
TE
1806
T1 Energy
TE
$1.19B
| $58.8K | ﹤0.01% |
+47,831
| New | +$58.3K |
|
1807
Kyverna Therapeutics
KYTX
$455M
| $58.7K | ﹤0.01% |
19,122
+3,847
| +25% | +$9.52K |
|
1808
Getty Images
GETY
$158M
| $57.8K | ﹤0.01% |
34,798
+24,195
| +228% | +$42.6K |
|
1809
TETRA Technologies
TTI
$1.13B
| $57.4K | ﹤0.01% |
+17,097
| New | +$49.8K |
|
1810
Prime Medicine
PRME
$545M
| $57.3K | ﹤0.01% |
23,191
+7,954
| +52% | +$12.3K |
|
1811
Chegg
CHGG
$118M
| $57.3K | ﹤0.01% |
47,333
+16,430
| +53% | +$15.2K |
|
|
RZLV
1812
Rezolve AI
RZLV
$949M
| $56.6K | ﹤0.01% |
+18,397
| New | +$36.2K |
|
|
ACB
1813
Aurora Cannabis
ACB
$175M
| $56.5K | ﹤0.01% |
13,325
+377
| +3% | +$1.83K |
|
1814
Kodiak Sciences
KOD
$2.66B
| $56.2K | ﹤0.01% |
15,070
+2,691
| +22% | +$9.53K |
|
1815
Rayonier Advanced Materials
RYAM
$604M
| $55.6K | ﹤0.01% |
14,442
-4,059
| -22% | -$17K |
|
1816
GSI Technology
GSIT
$224M
| $55.5K | ﹤0.01% |
+16,506
| New | +$50.3K |
|
1817
Sana Biotechnology
SANA
$904M
| $53.7K | ﹤0.01% |
19,685
+1,527
| +8% | +$3.15K |
|
1818
B&G Foods
BGS
$293M
| $53.4K | ﹤0.01% |
12,621
-8,775
| -41% | -$45.8K |
|
1819
JetBlue
JBLU
$2.29B
| $53.1K | ﹤0.01% |
12,554
-53,949
| -81% | -$241K |
|
|
AZUL
1820
DELISTED
Azul
AZUL
| $51.9K | ﹤0.01% |
+111,454
| New | +$115K |
|
1821
Caribou Biosciences
CRBU
$150M
| $51.4K | ﹤0.01% |
40,813
+16,736
| +70% | +$16.5K |
|
|
VMEO
1822
DELISTED
Vimeo
VMEO
| $50.9K | ﹤0.01% |
+12,605
| New | +$58.3K |
|
1823
CareCloud
CCLD
$102M
| $50.2K | ﹤0.01% |
+21,284
| New | +$40.5K |
|
1824
AirSculpt Technologies
AIRS
$342M
| $49.7K | ﹤0.01% |
+10,288
| New | +$34.9K |
|
1825
Aemetis
AMTX
$110M
| $48.6K | ﹤0.01% |
19,611
+6,420
| +49% | +$10.9K |
|
Similar funds
ACA
IIM
GI
OIA
RA
RI
WAM
HRCM
Vanguard Personalized Indexing Management's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Personalized Indexing Management held 2,054 positions worth $8.86B, up 31% from $6.78B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Vanguard Personalized Indexing Management deployed $1.22B of net new capital in Q2 2025, opening 215 new positions and adding to 1,370 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 128,038 shares worth $6.33M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Total World Stock ETF, an estimated $2.83M trimmed.
- Vanguard Personalized Indexing Management's largest Q2 2025 buy was Vanguard FTSE Emerging Markets ETF: 128,038 shares worth $6.33M.
- Vanguard Personalized Indexing Management added most to Microsoft in Q2 2025, an estimated $91M increase.
- Vanguard Personalized Indexing Management's biggest Q2 2025 reduction was Vanguard Total World Stock ETF, cutting an estimated $2.83M.
- Vanguard Personalized Indexing Management fully exited Discover Financial Services in Q2 2025, selling an estimated $6.47M.
- Vanguard Personalized Indexing Management's ten largest holdings make up 31% of its $8.86B portfolio in Q2 2025.
- Vanguard Personalized Indexing Management opened 215 new positions and closed 109 in Q2 2025.
- Vanguard Personalized Indexing Management's portfolio value rose 31% quarter-over-quarter to $8.86B.
Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2025, filed 25 Jul 2025.